IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
26.92
-0.57 (-2.07%)
At close: Oct 7, 2025, 4:00 PM EDT
26.92
0.00 (0.00%)
After-hours: Oct 7, 2025, 4:20 PM EDT
IDEAYA Biosciences Analyst Ratings
Total Analysts
15
Consensus Rating
Buy
Price Target
$47.92
Upside
+78.01%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +85.74% | Sep 18, 2025 |
| Mizuho | Mizuho | Buy Maintains $43 → $44 | Buy | Maintains | $43 → $44 | +63.45% | Sep 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $36 → $38 | Buy | Maintains | $36 → $38 | +41.16% | Sep 9, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 9, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $45 | Buy | Reiterates | $45 | +67.16% | Sep 9, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $41 → $45 | Buy | Maintains | $41 → $45 | +67.16% | Sep 8, 2025 |
| JMP Securities | JMP Securities | Buy Initiates $41 | Buy | Initiates | $41 | +52.30% | Sep 4, 2025 |
| Barclays | Barclays | Buy Initiates $40 | Buy | Initiates | $40 | +48.59% | Sep 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $72 → $74 | Buy | Maintains | $72 → $74 | +174.89% | Sep 3, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $66 → $72 | Buy | Maintains | $66 → $72 | +167.46% | Jul 28, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jul 22, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $57 → $30 | Buy | Maintains | $57 → $30 | +11.44% | Jul 9, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $44 | Buy | Initiates | $44 | +63.45% | Jun 26, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $63 → $66 | Buy | Maintains | $63 → $66 | +145.17% | May 22, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $50 | Buy | Reiterates | $50 | +85.74% | Feb 14, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $61 | Buy | Reiterates | $61 | +126.60% | Jan 15, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.